Works matching DE "PANITUMUMAB"

Results: 93
    1
    2

    Erratum.

    Published in:
    2024
    Publication type:
    Correction Notice
    3
    4
    5

    Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.

    Published in:
    Oncologist, 2024, v. 29, n. 5, p. 431, doi. 10.1093/oncolo/oyad320
    By:
    • Spiekman, Ilse A C;
    • Geurts, Birgit S;
    • Zeverijn, Laurien J;
    • Wit, Gijs F de;
    • van der Noort, Vincent;
    • Roepman, Paul;
    • Leng, Wendy W J de;
    • Jansen, Anne M L;
    • Kusters, Benno;
    • Beerepoot, Laurens V;
    • Vos, Filip Y F L de;
    • Groot, Derk-Jan A de;
    • Groot, Jan Willem B de;
    • Hoeben, Ann;
    • Buter, Jan;
    • Gelderblom, Hans A J;
    • Voest, Emile E;
    • Verheul, Henk M W
    Publication type:
    Article
    6
    7

    The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results.

    Published in:
    Oncologist, 2023, v. 28, n. 7, p. e565, doi. 10.1093/oncolo/oyac145
    By:
    • Terazawa, Tetsuji;
    • Kato, Takeshi;
    • Goto, Masahiro;
    • Ohta, Katsuya;
    • Satake, Hironaga;
    • Noura, Shingo;
    • Kagawa, Yoshinori;
    • Kawakami, Hisato;
    • Hasegawa, Hiroko;
    • Yanagihara, Kazuhiro;
    • Shingai, Tatsushi;
    • Nakata, Ken;
    • Kotaka, Masahito;
    • Hiraki, Masayuki;
    • Konishi, Ken;
    • Nakae, Shiro;
    • Sakai, Daisuke;
    • Kurokawa, Yukinori;
    • Shimokawa, Toshio;
    • Tsujinaka, Toshimasa
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study.

    Published in:
    Supportive Care in Cancer, 2021, v. 29, n. 7, p. 3971, doi. 10.1007/s00520-020-05972-2
    By:
    • Raimondi, Alessandra;
    • Corallo, Salvatore;
    • Lonardi, Sara;
    • Antoniotti, Carlotta;
    • Rimassa, Lorenza;
    • Amatu, Alessio;
    • Tampellini, Marco;
    • Racca, Patrizia;
    • Murialdo, Roberto;
    • Clavarezza, Matteo;
    • Zaniboni, Alberto;
    • Toscano, Giuseppe;
    • Tomasello, Gianluca;
    • Petrelli, Fausto;
    • Antonuzzo, Lorenzo;
    • Giordano, Monica;
    • Cinieri, Saverio;
    • Longarini, Raffaella;
    • Niger, Monica;
    • Antista, Maria
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges.

    Published in:
    Vaccines, 2022, v. 10, n. 4, p. N.PAG, doi. 10.3390/vaccines10040499
    By:
    • Janani, Balakarthikeyan;
    • Vijayakumar, Mayakrishnan;
    • Priya, Kannappan;
    • Kim, Jin Hee;
    • Prabakaran, D. S.;
    • Shahid, Mohammad;
    • Al-Ghamdi, Sameer;
    • Alsaidan, Mohammed;
    • Othman Bahakim, Nasraddin;
    • Hassan Abdelzaher, Mohammad;
    • Ramesh, Thiyagarajan
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.

    Published in:
    Journal of Oncology Pharmacy Practice, 2025, v. 31, n. 3, p. 404, doi. 10.1177/10781552241241004
    By:
    • Yildirim, Mahmut Emre;
    • Karadurmuş, Nuri;
    • Ökten, İlker Nihat;
    • Türk, Hacı Mehmet;
    • Urakçı, Zuhat;
    • Arslan, Çağatay;
    • Çelik, Sinemis;
    • Dane, Faysal;
    • Şendur, Mehmet Ali Nahit;
    • Bilir, Cemil;
    • Karabulut, Bülent;
    • Cicin, İrfan;
    • Çubukçu, Erdem;
    • Karaca, Mustafa;
    • Ozcelik, Melike;
    • Artaç, Mehmet;
    • Tanrikulu, Eda;
    • Alacacioglu, Ahmet;
    • Açıkgöz, Özgür;
    • Öven, Başak
    Publication type:
    Article
    41
    42

    Panitumumab Associated Acute Pancreatitis.

    Published in:
    Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1207, doi. 10.1177/10781552221073997
    By:
    • Arbag, Huseyin Can;
    • Sumbul, Hilmi Erdem;
    • Buyuksimsek, Mahmut;
    • Ogul, Ali;
    • Yetisir, Abdullah Evren;
    • Koseci, Tolga;
    • Bozkurt Duman, Berna;
    • Tohumcuoglu, Mert;
    • Kesen, Oguzhan;
    • Cil, Timucin
    Publication type:
    Article
    43
    44

    Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 10, p. 2681, doi. 10.1007/s00432-020-03257-z
    By:
    • Kurreck, A.;
    • Geissler, M.;
    • Martens, U. M.;
    • Riera-Knorrenschild, J.;
    • Greeve, J.;
    • Florschütz, A.;
    • Wessendorf, S.;
    • Ettrich, T.;
    • Kanzler, S.;
    • Nörenberg, D.;
    • Seidensticker, M.;
    • Held, S.;
    • Buechner-Steudel, P.;
    • Atzpodien, J.;
    • Heinemann, V.;
    • Stintzing, S.;
    • Seufferlein, T.;
    • Tannapfel, A.;
    • Reinacher-Schick, A. C.;
    • Modest, D. P.
    Publication type:
    Article
    45

    Erratum: Funding Acknowledgment.

    Published in:
    Journal of Clinical Practice & Research, 2023, v. 45, n. 4, p. 426, doi. 10.14744/cpr.2023.21931
    Publication type:
    Article
    46
    47
    48
    49
    50